Mirtazapine, bupropion and multimodal antidepressants — consultant viva

Opening (30–45 seconds)

These agents are phenotype-driven alternatives and sequential options after SSRIs/SNRIs: mirtazapine (NaSSA), bupropion (NDRI), and multimodal drugs such as vortioxetine, vilazodone and agomelatine. I match mechanism to sleep–appetite versus energy–sexual–smoking problems, name oral doses, and refuse casual polypharmacy or MAOI improvisation.^[1][9][10]